Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene
- 24 June 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 104 (1) , 49-53
- https://doi.org/10.1016/0304-3835(96)04228-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Glutamine synthetase and hepatocarcinogenesisCarcinogenesis: Integrative Cancer Research, 1995
- Interventive prophylaxis of liver cancerEuropean Journal Of Cancer Prevention, 1994
- Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liverCancer Letters, 1993
- Positive Foci of Glutathione S‐Transferase Placental Form in the Liver of Rats Given Furfural by Oral AdministrationJapanese Journal of Cancer Research, 1989
- Single GST-P positive liver cells — putative initiated. hepatocytesCarcinogenesis: Integrative Cancer Research, 1987
- Preneoplastic lesions as end points in carcinogenicity testing I. Hepatic preneoplasiaCarcinogenesis: Integrative Cancer Research, 1986
- Enhancing effect of butylated hydroxytoluene on the development of liver altered foci and neoplasms induced by N-2-fluorenylacetamide in ratsFood and Chemical Toxicology, 1984
- Induction by butylated hydroxytoluene of rat liver γ-glutamyl transpeptidase activity in comparison to expression in carcinogen-induced altered lesionsChemico-Biological Interactions, 1984
- Elevation of quinone reductase activity by anticarcinogenic antioxidantsAdvances in Enzyme Regulation, 1982
- A Letter from the Editor of Toxicologic PathologyToxicologic Pathology, 1982